Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799684050> ?p ?o ?g. }
- W2799684050 endingPage "141" @default.
- W2799684050 startingPage "134" @default.
- W2799684050 abstract "Objective Although systemic lupus erythematosus ( SLE ) is the most common autoimmune disease associated with antiphospholipid antibodies ( aPL ), limited data exist regarding the impact of SLE on the clinical phenotype of aPL ‐positive patients. The primary objective of this study was to compare the clinical, laboratory, and treatment characteristics of aPL ‐positive patients with SLE with those of aPL ‐positive patients without SLE. Methods A secure web‐based data capture system was used to store patient demographic characteristics and aPL ‐related clinical and laboratory characteristics. Inclusion criteria included positive aPL according to the updated Sapporo classification criteria. Antiphospholipid antibody–positive patients fulfilling the American College of Rheumatology criteria for the classification of SLE (“ aPL with SLE ”) and those with no other autoimmune diseases (“ aPL only”) were included in the analysis. Results Six hundred seventy‐two aPL ‐positive patients were recruited from 24 international centers; 426 of these patients did not have other autoimmune disease, and 197 had SLE . The frequency of thrombocytopenia, hemolytic anemia, low complement levels, and IgA anti–β 2 ‐glycoprotein I (anti‐β 2 GPI ) antibodies was higher in the aPL ‐positive patients with SLE , whereas the frequency of cognitive dysfunction and IgG anti‐β 2 GPI antibodies was higher in the aPL ‐only group. The frequency of arterial and venous thromboses (including recurrent) as well as pregnancy morbidity was similar in the 2 groups. The prevalence of cardiovascular disease risk factors at the time of entry into the registry entry did not differ between the 2 groups, with the exception of current smoking, which was more frequent in aPL ‐positive patients with SLE. Conclusion Although the frequencies of thrombosis and pregnancy morbidity are similar in aPL ‐positive patients with and those without SLE , the diagnosis of SLE in patients with persistently positive aPL is associated with an increased frequency of thrombocytopenia, hemolytic anemia, low complement levels, and positive IgA anti‐β 2 GPI antibodies." @default.
- W2799684050 created "2018-05-17" @default.
- W2799684050 creator A5000168500 @default.
- W2799684050 creator A5006335859 @default.
- W2799684050 creator A5011151808 @default.
- W2799684050 creator A5016039912 @default.
- W2799684050 creator A5019135832 @default.
- W2799684050 creator A5029153882 @default.
- W2799684050 creator A5029964821 @default.
- W2799684050 creator A5035234501 @default.
- W2799684050 creator A5043360954 @default.
- W2799684050 creator A5045704541 @default.
- W2799684050 creator A5052193063 @default.
- W2799684050 creator A5057315838 @default.
- W2799684050 creator A5059355333 @default.
- W2799684050 creator A5060417778 @default.
- W2799684050 creator A5061036069 @default.
- W2799684050 creator A5069242732 @default.
- W2799684050 creator A5069854712 @default.
- W2799684050 creator A5075020183 @default.
- W2799684050 creator A5077543168 @default.
- W2799684050 creator A5077713251 @default.
- W2799684050 creator A5079071350 @default.
- W2799684050 creator A5079447134 @default.
- W2799684050 creator A5082713013 @default.
- W2799684050 creator A5085330501 @default.
- W2799684050 creator A5091027078 @default.
- W2799684050 date "2018-12-27" @default.
- W2799684050 modified "2023-10-09" @default.
- W2799684050 title "The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository" @default.
- W2799684050 cites W1964598562 @default.
- W2799684050 cites W2001976130 @default.
- W2799684050 cites W2006292665 @default.
- W2799684050 cites W2014873778 @default.
- W2799684050 cites W2015256503 @default.
- W2799684050 cites W2024228574 @default.
- W2799684050 cites W2032097852 @default.
- W2799684050 cites W2036314008 @default.
- W2799684050 cites W2042958596 @default.
- W2799684050 cites W2047184949 @default.
- W2799684050 cites W2050117403 @default.
- W2799684050 cites W2054330426 @default.
- W2799684050 cites W2069797332 @default.
- W2799684050 cites W2070527591 @default.
- W2799684050 cites W2082490188 @default.
- W2799684050 cites W2093274439 @default.
- W2799684050 cites W2105482507 @default.
- W2799684050 cites W2120492526 @default.
- W2799684050 cites W2126052940 @default.
- W2799684050 cites W2132053014 @default.
- W2799684050 cites W2159860161 @default.
- W2799684050 cites W2297794063 @default.
- W2799684050 cites W2410132041 @default.
- W2799684050 cites W2417984802 @default.
- W2799684050 cites W2419133501 @default.
- W2799684050 cites W2460218540 @default.
- W2799684050 cites W2520079006 @default.
- W2799684050 cites W2538345017 @default.
- W2799684050 cites W2593137415 @default.
- W2799684050 cites W2741035577 @default.
- W2799684050 cites W3139375503 @default.
- W2799684050 cites W35408543 @default.
- W2799684050 cites W2612495075 @default.
- W2799684050 doi "https://doi.org/10.1002/acr.23584" @default.
- W2799684050 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6484425" @default.
- W2799684050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29669399" @default.
- W2799684050 hasPublicationYear "2018" @default.
- W2799684050 type Work @default.
- W2799684050 sameAs 2799684050 @default.
- W2799684050 citedByCount "34" @default.
- W2799684050 countsByYear W27996840502019 @default.
- W2799684050 countsByYear W27996840502020 @default.
- W2799684050 countsByYear W27996840502021 @default.
- W2799684050 countsByYear W27996840502022 @default.
- W2799684050 countsByYear W27996840502023 @default.
- W2799684050 crossrefType "journal-article" @default.
- W2799684050 hasAuthorship W2799684050A5000168500 @default.
- W2799684050 hasAuthorship W2799684050A5006335859 @default.
- W2799684050 hasAuthorship W2799684050A5011151808 @default.
- W2799684050 hasAuthorship W2799684050A5016039912 @default.
- W2799684050 hasAuthorship W2799684050A5019135832 @default.
- W2799684050 hasAuthorship W2799684050A5029153882 @default.
- W2799684050 hasAuthorship W2799684050A5029964821 @default.
- W2799684050 hasAuthorship W2799684050A5035234501 @default.
- W2799684050 hasAuthorship W2799684050A5043360954 @default.
- W2799684050 hasAuthorship W2799684050A5045704541 @default.
- W2799684050 hasAuthorship W2799684050A5052193063 @default.
- W2799684050 hasAuthorship W2799684050A5057315838 @default.
- W2799684050 hasAuthorship W2799684050A5059355333 @default.
- W2799684050 hasAuthorship W2799684050A5060417778 @default.
- W2799684050 hasAuthorship W2799684050A5061036069 @default.
- W2799684050 hasAuthorship W2799684050A5069242732 @default.
- W2799684050 hasAuthorship W2799684050A5069854712 @default.
- W2799684050 hasAuthorship W2799684050A5075020183 @default.
- W2799684050 hasAuthorship W2799684050A5077543168 @default.
- W2799684050 hasAuthorship W2799684050A5077713251 @default.
- W2799684050 hasAuthorship W2799684050A5079071350 @default.
- W2799684050 hasAuthorship W2799684050A5079447134 @default.